Cara Therapeutics Inc. sell StockNews.com
Start price
29.11.24
/
50%
€0.26
Target price
29.11.25
-
Performance (%)
30.97%
Price
30.12.24
€0.37
Summary
This prediction is currently active. The price for Cara Therapeutics Inc. has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 29.11.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cara Therapeutics Inc. | - | - |
| iShares Core DAX® | 2.339% | -0.341% |
| iShares Nasdaq 100 | 2.017% | 2.510% |
| iShares Nikkei 225® | 4.496% | 3.027% |
| iShares S&P 500 | 1.174% | 1.353% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
